Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Adults with mild type 2 diabetes might improve their insulin sensitivity by following a low-carb diet, thus potentially ...

A Chicago woman who has struggled with Type 1 diabetes since childhood is now off insulin, thanks to doctors at the ...

About 2 million Americans with Type 1 diabetes must take the medication to regulate their blood sugar because their bodies do not produce insulin. Millions more with Type 2 diabetes also take ...

Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Eknath Chavan, a 62-year-old man from Mumbai, celebrates his diabetes remission after 18 years, fitting into his wedding suit ...

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after ...